Table 1. Patient characteristics.

Except where indicated, data are means ± standard deviations, with ranges in parentheses

*Data are numbers of patients, with percentages in parentheses; CVP, central venous port

Parameter	All Patients (n = 21)	P-U Celsite (n = 12)	DewX Eterna (n = 9)
Age, y	54 ± 15 (30–73)	59 ± 13 (34–73)	47 ± 15 (30–72)
No. of men*	10 (48)	6 (50)	4 (56)
Body mass index	22.9 ± 3.9 (18–30.7)	23.2 ± 4.2 (18–30.7)	22.3 ± 3.5 (18.2–29.2)
Cervical subcutaneous fat thickness, mm	2.6 ± 1.4 (0.8–5.4)	2.8 ± 1.5 (0.8–5.4)	2.2 ± 1.2 (1.2–4.9)
Underlying disease*
Synovial sarcoma	1 (5)	1 (8)	0 (0)
Rhabdomyosarcoma	2 (10)	1 (8)	1 (11)
Liposarcoma	10 (48)	4 (33)	6 (67)
Leiomyosarcoma	4 (19)	2 (17)	2 (22)
Solitary fibrous tumor/hemangiopericytoma	3 (14)	3 (25)	0 (0)
Other sarcomas	1 (5)	1 (8)	0 (0)
No. of patients with right-side CVP implantation*	17 (81)	9 (75)	8 (89)
No. of total cycles of trabectedin infusion	3.2 ± 2.9 (1–14)	3.2 ± 3.7 (1–14)	3.3 ± 1.7 (1–6)